氨甲环酸减少内镜鼻窦手术术中出血的疗效:一项荟萃分析与系统评价
该系统评价与荟萃分析检索六个数据库至2018年7月,纳入7项研究共562名受试者,比较围手术期全身用氨甲环酸与安慰剂在内镜鼻窦手术中的效果。结果显示治疗组手术时间和术中出血量低于安慰剂组,术野质量和术者满意度高于安慰剂组,血流动力学、凝血功能及术后呕吐或血栓事件无显著差异。
要点
- 全身用氨甲环酸可缩短内镜鼻窦手术时间并减少术中出血。
- 治疗组术野质量和术者满意度均高于安慰剂组。
- 血流动力学、凝血功能及术后呕吐或血栓事件两组无显著差异。
核心结论
- 全身用氨甲环酸可减少内镜鼻窦手术术中出血并缩短手术时间,提高术者满意度,未引起术中血流动力学不稳定、术后呕吐事件或凝血功能异常。
- 纳入研究数量少,需进一步试验确认本研究结果。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、SCOPUS、Embase、Web of Science、Google Scholar和Cochrane数据库自建库至2018年7月。
- 纳入7项研究共562名受试者,比较围手术期氨甲环酸给药(治疗组)与安慰剂。
主要发现
- 手术时间标准化均数差(SMD)=-0.60,95%置信区间(CI)[-0.93, -0.29],治疗组低于安慰剂组。
- 术中出血量SMD=-0.66,95%CI[-0.86, -0.46],治疗组低于安慰剂组。
- 术野质量SMD=-0.80,95%CI[-1.12, -0.48],治疗组高于安慰剂组。
- 术者满意度SMD=1.74,95%CI[1.36, 2.13],治疗组高于安慰剂组。
- 血流动力学SMD=0.08,95%CI[-0.20, 0.37]及凝血功能SMD=-0.18,95%CI[-0.42, 0.07]两组无显著差异;氨甲环酸对呕吐或血栓事件无显著影响。
局限性
- 仅纳入少量研究,需进一步试验确认本研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tranexamic acid might help control bleeding during surgery because of antifibrinolytic characteristics. We aimed to evaluate the effectiveness of systemic tranexamic acid compared to control in blood loss, operative time, and surgical field and incidence of postoperative emesis and thromboembolism in endoscopic sinus surgery. METHODS: Two authors independently searched six databases (PubMed, SCOPUS, Embase, the Web of Science, Google Scholar, and the Cochrane database) from their inception to July 2018. The included studies compared perioperative tranexamic acid administration (treatment group) with a placebo, and the outcomes of interest were intraoperative morbidities, including surgical time, operative bleeding, and hypotension; postoperative morbidities such as nausea and vomiting; and coagulation profiles. RESULTS: Seven studies comprising 562 participants were reviewed in this study. Operative time (standardized mean difference (SMD) = -0.60; 95% confidence interval (CI)[-0.93, -0.29]) and intraoperative blood loss (SMD = -0.66; 95% CI [-0.86, -0.46]) were statistically lower in the treatment group than placebo group; and the quality of the surgical field (SMD = -0.80; 95% CI [-1.12; -0.48]) and surgeon satisfaction (SMD = 1.74; 95% CI [1.36; 2.13]) were statistically higher in the treatment group than the placebo group. By contrast, there were no significant differences in the hemodynamic (SMD = 0.08; 95% CI [-0.20; 0.37]) and coagulation profiles (SMD = -0.18; 95% CI [-0.42, 0.07]) of the two groups. Additionally, tranexamic acid had no significant effect on emetic or thrombotic events compared to placebo. CONCLUSION: This meta-analysis showed that the systemic administration of tranexamic acid could decrease operative time and blood loss intraoperatively, increasing the satisfaction of surgeons. It did not provoke intraoperative hemodynamic instability, postoperative emetic events, or coagulation profile abnormality. Only a small number of studies were enrolled, so further trials are needed to confirm the results of this study. Laryngoscope, 129:800-807, 2019.
引用
- Kim DH, Kim S, Kang H, et al. Efficacy of tranexamic acid on operative bleeding in endoscopic sinus surgery: A meta-analysis and systematic review. Laryngoscope. 2018. PMID: 30593688. doi:10.1002/lary.27766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。